Boston Scientific stock down 0.4% on market changes
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowBoston Scientific (BSX) shares fell by 0.4% in pre-market trading, reflecting broader market trends and trading volumes today. The decline followed announcements of upcoming financial results, which could influence investor sentiment. The stock's decline is part of a larger trend observed in the medical devices sector, where several companies are facing similar issues. For investors, this trend could indicate potential volatility and caution in future trading sessions.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Boston Scientific Corporation (BSX)
Boston Scientific makes medical devices for cardiology and other specialties.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier BSX news
- Boston Scientific (BSX) reports $5.4B Q2 revenue with 7.5% growth
- Boston Scientific (BSX) Price Target Cut to $64 by Truist
- Boston Scientific (BSX) Price Target Cut by Jefferies on Growth Outlook
- Boston Scientific Reports Clinical Trials Driving Growth in Cardiology Market
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
